Search

everythinglearnresearchcommunity

for

Search:↓

The combined Myo-inositol and D-chiro-inositol treatment improved weight, hormone levels, and skin conditions in women with PCOS.

Platelet-rich plasma can help thicken the endometrium and improve pregnancy rates.

Certain changes in the VEGF gene can increase or decrease the risk of polycystic ovary syndrome.

The conclusion is that proper diagnosis and long-term treatment, including medication, hair removal, and lifestyle changes, are important for improving hirsutism, especially in PCOS patients.

New ultrasound criteria for diagnosing PCOS in North African patients were successfully established.

Treating non-classic congenital adrenal hyperplasia is complex because the benefits of hormone treatment must be weighed against potential health risks.

Accurate diagnosis of hyperandrogenism, especially PCOS, is crucial for managing fertility and metabolic risks in women.

PCOS symptoms can improve with specific treatments for pituitary adenomas.

Personalized treatment is crucial for women with hyperandrogenism-related acne and hirsutism.

Cell-free fat extract may boost IVF success in older women with past failures.

Hyperandrogenism in women often causes acne and excess hair, treatable with personalized plans including weight loss, hair removal, and medications.

Herbal remedies like Asparagus racemosus and Tinospora cordifolia may help manage PCOS symptoms.

Hyperandrogenism in women often causes acne and excess hair, treatable with lifestyle changes and medications.

Metformin effectively reduces hormone levels in women with PCOS.

5α-reductase enzymes are crucial in certain disorders, and while treatment advances exist, more research on SRD5A3 is needed.

Women with Polycystic Ovary Syndrome (PCOS) have a higher risk of developing type 2 diabetes due to insulin resistance.

Endocrine therapy helps with reproductive and metabolic issues in women with PCOS.

Hyperandrogenism, often causing excessive hair growth and acne, can be treated with methods like weight reduction, hair removal, various medications, and in the case of acne, topical treatments.

A patient with HAIR-AN syndrome, PCOS, and Hashimoto's thyroiditis improved with early diagnosis and treatment to prevent serious health problems.

Polycystic ovary syndrome (PCOS) was first described in 1721, officially diagnosed in the 1990s, and is now known to be partly genetic and linked to insulin resistance, with increased risk of cardiovascular disease and carbohydrate metabolism issues.

Certain brain hormones and chemicals are linked to the development of Polycystic Ovary Syndrome.

Metformin and liraglutide improved symptoms of HAIR-AN syndrome in a child.

Androgen receptors are active in many tissues of both male and female mice, not just reproductive organs.

17β-estradiol can reduce inflammation in the skin.

Understanding EGFR roles could lead to new hair loss treatments.

The rat model showed early perimenopause with regular cycles and low hormones, and late perimenopause with irregular cycles and higher hormone levels.

OCT4 helps granulosa cell growth in early-stage follicles, and FSH increases OCT4 through specific pathways.

EZH2 is crucial for uterine gland development and female fertility.

A model using hormone levels, cycle length, and BMI can help identify PCOS in Chinese women but isn't for screening teens.

Long-term breastfeeding and preterm labor may worsen postpartum hair loss.